| Literature DB >> 28025003 |
Sung Hee Hwang1, Karen Wagner1, Jian Xu2, Jun Yang1, Xichun Li2, Zhengyu Cao2, Christophe Morisseau1, Kin Sing Stephen Lee1, Bruce D Hammock3.
Abstract
ω-Hydroxy polyunsaturated fatty acids (PUFAs), natural metabolites from arachidonic acid (ARA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were prepared via convergent synthesis approach using two key steps: Cu-mediated CC bond formation to construct methylene skipped poly-ynes and a partial alkyne hydrogenation where the presence of excess 2-methyl-2-butene as an additive that is proven to be critical for the success of partial reduction of the poly-ynes to the corresponding cis-alkenes without over-hydrogenation. The potential biological function of ω-hydroxy PUFAs in pain was evaluated in naive rats. Following intraplantar injection, 20-hydroxyeicosatetraenoic acid (20-HETE, ω-hydroxy ARA) generated an acute decrease in paw withdrawal thresholds in a mechanical nociceptive assay indicating pain, but no change was observed from rats which received either 20-hydroxyeicosapentaenoic acid (20-HEPE, ω-hydroxy EPA) or 22-hydroxydocosahexaenoic acid (22-HDoHE, ω-hydroxy DHA). We also found that both 20-HEPE and 22-HDoHE are more potent than 20-HETE to activate murine transient receptor potential vanilloid receptor1 (mTRPV1).Entities:
Keywords: 20-HEPE; 20-HETE; 22-HDoHE; Pain; TRPV1; ω-Hydroxy PUFA
Mesh:
Substances:
Year: 2016 PMID: 28025003 PMCID: PMC5584617 DOI: 10.1016/j.bmcl.2016.12.002
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823